It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
We introduce and validate four adaptive models (AMs) to perform a physiologically based Nested-Model-Selection (NMS) estimation of such microvascular parameters as forward volumetric transfer constant, Ktrans, plasma volume fraction, vp, and extravascular, extracellular space, ve, directly from Dynamic Contrast-Enhanced (DCE) MRI raw information without the need for an Arterial-Input Function (AIF). In sixty-six immune-compromised-RNU rats implanted with human U-251 cancer cells, DCE-MRI studies estimated pharmacokinetic (PK) parameters using a group-averaged radiological AIF and an extended Patlak-based NMS paradigm. One-hundred-ninety features extracted from raw DCE-MRI information were used to construct and validate (nested-cross-validation, NCV) four AMs for estimation of model-based regions and their three PK parameters. An NMS-based a priori knowledge was used to fine-tune the AMs to improve their performance. Compared to the conventional analysis, AMs produced stable maps of vascular parameters and nested-model regions less impacted by AIF-dispersion. The performance (Correlation coefficient and Adjusted R-squared for NCV test cohorts) of the AMs were: 0.914/0.834, 0.825/0.720, 0.938/0.880, and 0.890/0.792 for predictions of nested model regions, vp, Ktrans, and ve, respectively. This study demonstrates an application of AMs that quickens and improves DCE-MRI based quantification of microvasculature properties of tumors and normal tissues relative to conventional approaches.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Henry Ford Health, Department of Radiation Oncology, Detroit, USA (GRID:grid.239864.2) (ISNI:0000 0000 8523 7701); Michigan State University, Department of Radiology, East Lansing, USA (GRID:grid.17088.36) (ISNI:0000 0001 2150 1785); Michigan State University, Department of Osteopathic Medicine, East Lansing, USA (GRID:grid.17088.36) (ISNI:0000 0001 2150 1785); Oakland University, Department of Physics, Rochester, USA (GRID:grid.261277.7) (ISNI:0000 0001 2219 916X)
2 Henry Ford Health, Department of Radiation Oncology, Detroit, USA (GRID:grid.239864.2) (ISNI:0000 0000 8523 7701); Michigan State University, Department of Radiology, East Lansing, USA (GRID:grid.17088.36) (ISNI:0000 0001 2150 1785); Wayne State University, Department of Radiation Oncology, Detroit, USA (GRID:grid.254444.7) (ISNI:0000 0001 1456 7807)
3 Michigan State University, Department of Computer Science and Engineering, East Lansing, USA (GRID:grid.17088.36) (ISNI:0000 0001 2150 1785)
4 Michigan State University, Department of Radiology, East Lansing, USA (GRID:grid.17088.36) (ISNI:0000 0001 2150 1785); Henry Ford Health, Department of Neurosurgery, Detroit, USA (GRID:grid.239864.2) (ISNI:0000 0000 8523 7701)
5 Wayne State University, Department of Radiation Oncology, Detroit, USA (GRID:grid.254444.7) (ISNI:0000 0001 1456 7807)
6 Oakland University, Department of Physics, Rochester, USA (GRID:grid.261277.7) (ISNI:0000 0001 2219 916X)
7 Henry Ford Health, Department of Neurology, Detroit, USA (GRID:grid.239864.2) (ISNI:0000 0000 8523 7701)
8 Henry Ford Health, Department of Public Health Sciences, Detroit, USA (GRID:grid.239864.2) (ISNI:0000 0000 8523 7701); Michigan State University, Department of Epidemiology and Biostatistics, E. Lansing, USA (GRID:grid.17088.36) (ISNI:0000 0001 2150 1785)
9 Henry Ford Health, Department of Neurosurgery, Detroit, USA (GRID:grid.239864.2) (ISNI:0000 0000 8523 7701)
10 Henry Ford Health, Department of Radiation Oncology, Detroit, USA (GRID:grid.239864.2) (ISNI:0000 0000 8523 7701); Oakland University, Department of Physics, Rochester, USA (GRID:grid.261277.7) (ISNI:0000 0001 2219 916X); Wayne State University, Department of Radiation Oncology, Detroit, USA (GRID:grid.254444.7) (ISNI:0000 0001 1456 7807)
11 Michigan State University, Department of Radiology, East Lansing, USA (GRID:grid.17088.36) (ISNI:0000 0001 2150 1785); Oakland University, Department of Physics, Rochester, USA (GRID:grid.261277.7) (ISNI:0000 0001 2219 916X); Henry Ford Health, Department of Neurosurgery, Detroit, USA (GRID:grid.239864.2) (ISNI:0000 0000 8523 7701); Henry Ford Health, Department of Neurology, Detroit, USA (GRID:grid.239864.2) (ISNI:0000 0000 8523 7701); Wayne State University, Department of Neurology, Detroit, USA (GRID:grid.254444.7) (ISNI:0000 0001 1456 7807)